These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23297423)

  • 1. How do cardiologists face health economics and health technology assessments?
    Boriani G
    Eur Heart J; 2012 Nov; 33(22):2757-8. PubMed ID: 23297423
    [No Abstract]   [Full Text] [Related]  

  • 2. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 3. IQWiG: an opportunity lost?
    Jönsson B
    Eur J Health Econ; 2008 Aug; 9(3):205-7. PubMed ID: 18496721
    [No Abstract]   [Full Text] [Related]  

  • 4. To use technology better.
    Garber AM
    Health Aff (Millwood); 2006; 25(2):w51-3. PubMed ID: 16464903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transparency of economic evaluations of health technologies.
    Rovira J
    Pharmacoeconomics; 2008; 26(3):181-3. PubMed ID: 18282013
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review.
    Gallego G; Harris A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):615-7. PubMed ID: 21155692
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic data transferability for HTA: are we there yet?
    Manca A
    Value Health; 2009 Jun; 12(4):407. PubMed ID: 19900247
    [No Abstract]   [Full Text] [Related]  

  • 8. Making sense of medical technology.
    Cutler DM
    Health Aff (Millwood); 2006; 25(2):w48-50. PubMed ID: 16464902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early dialogue between the developers of new technologies and pricing and reimbursement agencies: a pilot study.
    Backhouse ME; Wonder M; Hornby E; Kilburg A; Drummond M; Mayer FK
    Value Health; 2011 Jun; 14(4):608-15. PubMed ID: 21669387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions.
    Frederix GW; Haji Ali Afzali H; Dasbach EJ; Ward RL
    Pharmacoeconomics; 2015 Aug; 33(8):777-81. PubMed ID: 25827099
    [No Abstract]   [Full Text] [Related]  

  • 11. Health technology assessment (HTA) groups have been instrumental in restricting patient access to PET worldwide.
    Ware R
    J Nucl Med; 2004 Dec; 45(12):1977. PubMed ID: 15641205
    [No Abstract]   [Full Text] [Related]  

  • 12. 5 ways to use medical technology assessments to reduce costs.
    Niederhausen J
    Healthc Financ Manage; 2014 Aug; 68(8):32. PubMed ID: 25145028
    [No Abstract]   [Full Text] [Related]  

  • 13. Guiding the process of health technology disinvestment.
    Ibargoyen-Roteta N; Gutiérrez-Ibarluzea I; Asua J
    Health Policy; 2010 Dec; 98(2-3):218-26. PubMed ID: 20638745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in cardiology and escalating costs to the patient: a view from the government.
    Lenfant C; Roth CA
    Circulation; 1985 Mar; 71(3):424-8. PubMed ID: 3871668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indirect costs in health technology assessment].
    Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
    Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As cardiology market matures, technology's impact is clearer.
    Sabatino F
    Hospitals; 1990 Oct; 64(20):62, 64, 66-8. PubMed ID: 2227864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for the early health technology assessment of novel biomarker measurement in primary prevention programs.
    Postmus D; de Graaf G; Hillege HL; Steyerberg EW; Buskens E
    Stat Med; 2012 Oct; 31(23):2733-44. PubMed ID: 22806952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Philipson TJ; Jena AB
    AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
    [No Abstract]   [Full Text] [Related]  

  • 19. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.